What is Haemonetics's net change in cash?

Haemonetics (HAE) reported net change in cash of -$117.93M in Q1 2026.

What is the long-term trend for Haemonetics's net change in cash?

Over 3 years (2022 to 2026), Haemonetics's net change in cash has grown at a -1.2% compound annual growth rate (CAGR), from $67.19M to -$64.85M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Haemonetics HAE Net Change in Cash

Net Change in Cash at other companies

AbbottABT

-$1.72B-58.6%

TFX

TeleflexTFX

-$84.85M-734%

Boston ScientificBSX

-$504M-261%

MedtronicMDT

-$136M+11.7%

LivaNovaLIVN

-$95.85M-744%

ICU MedicalICUI

-$19.63M-4.1%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's net change in cash?: Haemonetics (HAE) reported net change in cash of -$117.93M in Q1 2026.
What is the long-term trend for Haemonetics's net change in cash?: Over 3 years (2022 to 2026), Haemonetics's net change in cash has grown at a -1.2% compound annual growth rate (CAGR), from $67.19M to -$64.85M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.